Galit Yahalom holds a Ph.D. from the Weizmann Institute of Science and has more than 10 years of experience in the medical device and diagnostic world.

 

She was one of the founders of EventusDx which developed the first to market blood based diagnosis for breast cancer. During her prosperous career, she experienced all the developmental stages of a clinical product – starting with an idea, all through the supportive intensive R&D, establishing the infrastructure for the global clinical trials that supported the product and receiving the regulatory approvals for the product. She was involved in market penetration and business development activities.

During her working years, she was exposed to the complexity of the medical and diagnostic world, led global clinical trials with KOL, with whom she established strong professional relationaships and was actively involved in developing regulation strategies.